Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27059909 | 0.89 | KDM4E (0.36) | KDM4EATML3MBTL1ALDH1A1ALKBH5 | |
| SCHEMBL23919626 | 0.88 | ALKBH5 (0.46) | KDM4EATML3MBTL1ALDH1A1ALKBH5 | |
| SCHEMBL23919892 | 0.88 | MAOA (0.42) | ALDH1A1DUSP3 | |
| SCHEMBL23919581 | 0.86 | ALKBH5 (0.47) | KDM4EATML3MBTL1ALDH1A1ALKBH5 | |
| SCHEMBL23919628 | 0.86 | DUSP3 (0.35) | KDM4EATML3MBTL1ALDH1A1DUSP3 | |
| SCHEMBL23919577 | 0.85 | MAOB (0.35) | KDM4EATML3MBTL1ALDH1A1DUSP3 | |
| SCHEMBL23919571 | 0.84 | DUSP3 (0.35) | KDM4EATML3MBTL1ALDH1A1DUSP3 | |
| SCHEMBL23919653 | 0.83 | IMPDH2 (0.34) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL25507781 | 0.83 | ALKBH5 (0.32) | KDM4EATML3MBTL1ALDH1A1ALKBH5 | |
| SCHEMBL25507768 | 0.83 | KIF11 (0.35) | L3MBTL1ALDH1A1ALKBH5FTODUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| EP-3892704-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, OXER1, OXSR1 | KDM4E 2931/4885ATM 3661/4885L3MBTL1 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.